Cargando…

Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate

OBJECTIVES: Buffered low-dose sublingual transmucosal zolpidem lozenge hemitartrate (ST zolpidem) is being developed for the treatment of middle-of-the-night insomnia. The objective of this double-blind placebo-controlled cross-over study (n = 24) was to evaluate the pharmacokinetics (PK) and daytim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roth, Thomas, Mayleben, David, Corser, Bruce C, Singh, Nikhilesh N
Formato:	Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871168/ https://www.ncbi.nlm.nih.gov/pubmed/17907263 http://dx.doi.org/10.1002/hup.884

Ejemplares similares

Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness
por: Pergolizzi, Joseph V., et al.
Publicado: (2014)

Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem
por: Yoon, Seonghae, et al.
Publicado: (2021)

Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor
por: Cubała, Wiesław Jerzy, et al.
Publicado: (2010)

Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial
por: Castro, Laura S., et al.
Publicado: (2019)

Safety, Pharmacokinetic, and Pharmacodynamic Study of a Sublingual Formula for the Treatment of Vasovagal Syncope
por: Hutson, Paul, et al.
Publicado: (2022)

Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs
por: Enomoto, Hiroko, et al.
Publicado: (2022)

Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs
por: della Rocca, Giorgia, et al.
Publicado: (2023)

Comparative pharmacokinetics of zolpidem tartrate in five ethnic populations of China
por: Guo, Tao, et al.
Publicado: (2014)

Feasibility of a transmucosal sublingual fentanyl tablet as a procedural pain treatment in colonoscopy patients: a prospective placebo-controlled randomized study
por: Fihlman, Mari, et al.
Publicado: (2020)

Silica Nanoparticles in Transmucosal Drug Delivery
por: M. Ways, Twana Mohammed, et al.
Publicado: (2020)

ZOLPIDEM INDUCED DELIRIUM
por: Sidana, Ajeet, et al.
Publicado: (2002)

Transmucosal Delivery of Tocotrienols From a Delta-Tocotrienol Powder: A Multidose Pharmacokinetic Study
por: Moon, Jordan, et al.
Publicado: (2022)

An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home
por: Lyu, Xiao-Juan, et al.
Publicado: (2022)

New approaches in the treatment of short term and middle of the night insomnia: emerging evidence for a role for sublingual zolpidem tablets
por: Ownby, Raymond L
Publicado: (2010)

Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
por: White, Nicholas J.
Publicado: (2013)

Persistent Psychosis after Abuse of High Dose of Zolpidem
por: Eslami-Shahrbabaki, Mahin, et al.
Publicado: (2014)

Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial
por: Rosenberg, Russell, et al.
Publicado: (2019)

Transmucosal Absorption Enhancers in the Drug Delivery Field
por: Maher, Sam, et al.
Publicado: (2019)

The Potential of Films as Transmucosal Drug Delivery Systems
por: de Carvalho, Ana Clara Wada, et al.
Publicado: (2023)

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
por: Verheijen, Remy B., et al.
Publicado: (2017)

Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic Perspective
por: Le Louedec, Félicien, et al.
Publicado: (2020)

Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses
por: Serra López-Matencio, Jose M., et al.
Publicado: (2021)

Pharmacokinetics and pharmacodynamics of repeat dosing of gabapentin in adult horses
por: Gold, Jenifer R., et al.
Publicado: (2022)

The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing
por: Smith, Joe S., et al.
Publicado: (2023)

Zolpidem withdrawal delirium
por: Mattoo, Surendra K., et al.
Publicado: (2011)

Zolpidem for the Treatment of Dystonia
por: Badillo, Stephanie Patricia J., et al.
Publicado: (2019)

Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban
por: Frost, Charles E., et al.
Publicado: (2015)

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
por: Kato, Hideo, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin–Tazobactam in Obese Patients
por: Veillette, John J., et al.
Publicado: (2021)

Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain
por: Mercadante, S, et al.
Publicado: (2007)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
por: McCarthy, Matthew William
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

Zolpidem modified-release in insomnia
por: Kirkwood, Cynthia, et al.
Publicado: (2007)

Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013)

Transmucosal Delivery of Nicotine in Combination with Tincture of Benzoin Inhibits Apoptosis
por: Battaglia, Alex, et al.
Publicado: (2017)

Preliminary Study for the Preparation of Transmucosal or Transdermal Patches with Acyclovir and Lidocaine
por: Marioane, Cristina-Adela, et al.
Publicado: (2021)

Transmucosal Buprenorphine in the Treatment of Dyspnea: Case Series and Review of the Literature
por: Blumenfeld-Kouchner, François, et al.
Publicado: (2021)

Stimuli-Responsive Polymers for Transdermal, Transmucosal and Ocular Drug Delivery
por: Berillo, Dmitriy, et al.
Publicado: (2021)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
por: Family, Neiloufar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lbu6qgffp2uv87iep48ruh0cep